Werewolf Therapeutics Inc (HOWL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -70,515 | -37,368 | -53,810 | -49,983 | -15,040 |
| Depreciation Amortization | 1,814 | 1,824 | 1,307 | 216 | 150 |
| Accounts receivable | 1,350 | 5,578 | -6,928 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,455 | -4,335 | 3,046 | 1,007 | 388 |
| Other Working Capital | 2,526 | -5,894 | 2,539 | 2,277 | 2,308 |
| Other Operating Activity | 5,182 | 7,583 | 13,250 | 3,607 | -6,430 |
| Operating Cash Flow | $-56,188 | $-32,612 | $-40,596 | $-42,876 | $-18,624 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -254 | -769 | -3,611 | -498 | -560 |
| Investing Cash Flow | $-254 | $-769 | $-3,611 | $-498 | $-560 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 30,000 | 40,000 | N/A | N/A | N/A |
| Debt Repayment | -40,000 | 0 | N/A | N/A | N/A |
| Common Stock Issued | 23,753 | 18,429 | 15,994 | 111,805 | 26 |
| Other Financing Activity | -673 | 0 | -88 | -2,378 | 93,831 |
| Financing Cash Flow | $13,080 | $58,429 | $15,906 | $109,427 | $93,857 |
| Beginning Cash Position | 155,577 | 130,529 | 158,830 | 92,777 | 18,104 |
| End Cash Position | 112,215 | 155,577 | 130,529 | 158,830 | 92,777 |
| Net Cash Flow | $-43,362 | $25,048 | $-28,301 | $66,053 | $74,673 |
| Free Cash Flow | |||||
| Operating Cash Flow | -56,188 | -32,612 | -40,596 | -42,876 | -18,624 |
| Capital Expenditure | -254 | -769 | -3,611 | -498 | -560 |
| Free Cash Flow | -56,442 | -33,381 | -44,207 | -43,374 | -19,184 |